Recent research reveals that bacteria residing inside tumors could become a powerful tool in combating cancer. These bacteria produce 2-methylisocitrate, a molecule that enhances the effectiveness of chemotherapy by increasing cancer cells' susceptibility through DNA damage and metabolic disruption.
Researchers from Europe have engineered a synthetic molecule inspired by a natural bacterial compound, showing promise in enhancing chemotherapy effectiveness against cancer.
Scientists at MIT have developed 'bottlebrush' nanoparticles that can deliver large doses of chemotherapy drugs directly to cancer cells, potentially reducing treatment side effects. These specialized particles are engineered with antibodies that guide them precisely to tumor sites, heralding a new era in targeted cancer therapies.
Stay informed with curated insights delivered weekly to your inbox.